Shares of GSK PLC GSK slid 4.90% to £13.79 Wednesday, on what proved to be an all-around rough trading session for the stock ...

Q1 2025 Earnings Call Transcript April 30, 2025 GSK plc beats earnings expectations. Reported EPS is $1.13, expectations were ...

Royalty Income for 2025: Expected to be GBP 750 to 800 million. GSK PLC (NYSE:GSK) reported a 4% increase in group sales and a 5% rise in operating profit, demonstrating the strength and ...

GSK plc's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 ...

Royalty Income for 2025: Expected to be GBP 750 to 800 million. GSK PLC (NYSE:GSK) reported a 4% increase in group sales and a 5% rise in operating profit, demonstrating the strength and resilience of ...

Strahlman currently works at Altria Group, Inc., as Independent Director from 2020, Losonoco Ltd., as Director from 2009, and Eyenovia, Inc., as Independent Director from 2022. Dr. Strahlman also ...

There is no Morningstar’s Analysis data available. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...